Pneumonia in HIV-Infected Patients

Objective & Hypothesis:purpose of this review is to investigate the correlation between an immune system destroyed by HIV and the frequency of pneumonia.

📊

Key Findings & Data:Observational studies show that respiratory diseases are among the most common infections observed in HIV-infected patients.

💡

Conclusion & Impact:Pneumococcus-based polysaccharide vaccine is recommended to avoid some type of specific bacterial pneumonia.

🔬Design:Review & Systematic Survey

📍Scope:Comprehensive Sample

⚙️Variables:Domain Parameters

Abstract

purpose of this review is to investigate the correlation between an immune system destroyed by HIV and the frequency of pneumonia. Observational studies show that respiratory diseases are among the most common infections observed in HIV-infected patients. In addition, pneumonia is the leading cause of morbidity and mortality in HIV-infected patients. According to articles in literature, in addition to antiretroviral therapy (ART) or highly active antiretroviral therapy (HAART), the use of prophylaxis provides favorable results for the treatment of pneumonia. Here we conduct a systematic literature review to determine the pathogenesis and causative agents of bacterial pneumonia, tuberculosis (TB), nontuberculous mycobacterial disease, fungal pneumonia, Pneumocystis pneumonia, viral pneumonia and parasitic infections and the prophylaxis in addition to ART and HAART for treatment. Pneumococcus-based polysaccharide vaccine is recommended to avoid some type of specific bacterial pneumonia.

🔖

Cite This Article

TURAL, S. Ö., DALAR, L., İLİAZ, S., YALÇIN, A. D. (2016). Pneumonia in HIV-Infected Patients. Solunum, Cilt: 18 - Sayı: 1, 11–17. https://ajindex.com/articles/314486

📄 Full Text PDF Viewer

Open in New Tab ↗

↗New Tab

📄

PDF görüntüleyici hazırlanıyor...

References (2)

Morris A, Crothers K, Beck JM, Huang L; American Thoracic Society Com- mittee on HIV Pulmonary Disease. An Official ATS Workshop Report: Emerging Issues and Current Controversies in HIV-Associated Pulmo- nary Diseases. Proc Am Thorac Soc 2011; 8: 17-26. [CrossRef] Pezzotti P, Dorrucci M, Donisi A, Cusini M, Mazzarello G, De Luca A, et al. Survival, progression to AIDS and immunosuppression in HIV-positive individuals before and after the introduction of the highly active anti- retroviral therapy (HAART). Epidemiol Prev 2003; 27: 348-55.
Staitieh B, Guidot DM. Noninfectious pulmonary complications of hu- man immunodeficiency virus infection. Am J Med Sci 2014; 348: 502-11. [CrossRef] Bao Z, Rong X, Cheng Q, Zhou M, Gong Q, Shi G, et al. Clinical and micro- biological characteristics of community-acquired pneumonia in human immunodeficiency virus-infected patients: a retrospective analysis of 79 HIV/AIDS patients. Clin Respir J 2014; 8: 255-61. [CrossRef] Fei MW, Kim EJ, Sant CA, Jarlsberg LG, Davis JL, Swartzman A, et al. Predi- cting mortality from HIV-associated Pneumocystis pneumonia at illness presentation: an observational cohort study. Thorax 2009; 64: 1070-6. Almodovar S. The Complexity of HIV Persistence and Pathogenesis in the Lung Under Antiretroviral Therapy: Challenges Beyond AIDS. Viral Immunol 2014; 27: 186-99. [CrossRef] Crothers K, Griffith TA, McGinnis KA, Rodriguez-Barradas MC, Leaf DA, Weissman S, et al. The impact of cigarette smoking on mortality, quality of life, and comorbid illness among HIV-positive veterans. J Gen Intern Med 2005; 20: 1142-5. [CrossRef] Steel HC, Cockeran R, Anderson R, Feldman C. Overview of commu- nity-acquired pneumonia and the role of inflammatory mechanisms in the immunopathogenesis of severe pneumococcal disease. Mediators Inflamm 2013; 2013: 490346. [CrossRef] Park DR, Sherbin VL, Goodman MS, Pacifico AD, Rubenfeld GD, Polissar NL, et al. Harborview CAP Study Group. The etiology of community-a- cquired pneumonia at an urban public hospital: influence of human im- munodeficiency virus infection and initial severity of illness. J Infect Dis 2001; 184: 268-77. [CrossRef] Benito N, Moreno A, Miro JM, Torres A. Pulmonary infections in HIV-infec- ted patients: an update in the 21st century. Eur Respir J 2012; 39: 730-45. [CrossRef] Afessa B, Green B. Bacterial pneumonia in hospitalized patients with HIV infection: the Pulmonary Complications, ICU Support, and Prognostic Factors of Hospitalized Patients with HIV (P